Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners

Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners

US Patent 5366977 · Granted Nov 22, 1994

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

A1 adenosine receptor agonists and methods of use thereof2025
Compounds and methods for treating neurological and cardiovascular conditions2025
Treatment and prevention of neuropathic pain with P2Y14 antagonists2023
Heterocyclic P2Y14 receptor antagonists2023
Biomarkers for diagnosing post traumatic stress disorder2021
Methods for pharmacologic treatment of stroke2020
Triazole derivatives as P2Y14 receptor antagonists2020
A3 adenosine receptor agonists2020
MicroRNA biomarkers for posttraumatic stress disorder and methods of use thereof2019
Methanocarba derivatives of pseudoribose that inhibit adenosine kinase2018
A3 adenosine receptor agonists2018
Compositions and methods to treat cardiac diseases2016